Natarajavelalar Balasubramaniyan
Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 10 | 2023 | 219 | 1.500 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 13 | 2021 | 209 | 1.130 |
Why?
| | Transcriptional Activation | 5 | 2016 | 382 | 0.890 |
Why?
| | ATP-Binding Cassette Transporters | 11 | 2016 | 118 | 0.820 |
Why?
| | Gene Expression Regulation | 11 | 2021 | 2603 | 0.820 |
Why?
| | Liver | 14 | 2024 | 1884 | 0.780 |
Why?
| | Transcription Factor RelA | 3 | 2024 | 85 | 0.710 |
Why?
| | MicroRNAs | 2 | 2021 | 700 | 0.550 |
Why?
| | Hepatocytes | 7 | 2024 | 221 | 0.510 |
Why?
| | Bile Acids and Salts | 10 | 2023 | 164 | 0.480 |
Why?
| | Response Elements | 1 | 2016 | 89 | 0.460 |
Why?
| | Sumoylation | 1 | 2013 | 18 | 0.390 |
Why?
| | NF-kappa B | 4 | 2024 | 661 | 0.390 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2012 | 141 | 0.390 |
Why?
| | Acetaminophen | 2 | 2026 | 264 | 0.380 |
Why?
| | Uterine Cervical Neoplasms | 4 | 1995 | 267 | 0.340 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2012 | 905 | 0.310 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2024 | 1217 | 0.310 |
Why?
| | Endotoxemia | 2 | 2024 | 87 | 0.300 |
Why?
| | Signal Transduction | 8 | 2026 | 5221 | 0.300 |
Why?
| | Mice | 21 | 2026 | 18329 | 0.290 |
Why?
| | Immunity, Innate | 2 | 2026 | 846 | 0.290 |
Why?
| | Animals | 37 | 2026 | 38030 | 0.270 |
Why?
| | Promoter Regions, Genetic | 10 | 2016 | 1255 | 0.260 |
Why?
| | Toll-Like Receptor 9 | 1 | 2026 | 37 | 0.240 |
Why?
| | Parenteral Nutrition | 3 | 2021 | 105 | 0.240 |
Why?
| | Mice, Inbred C57BL | 8 | 2026 | 5988 | 0.230 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 6 | 2011 | 14 | 0.220 |
Why?
| | Protein Binding | 6 | 2016 | 2270 | 0.220 |
Why?
| | Kidney | 3 | 2012 | 1495 | 0.220 |
Why?
| | Mice, Knockout | 6 | 2026 | 3119 | 0.220 |
Why?
| | Carrier Proteins | 6 | 2020 | 736 | 0.220 |
Why?
| | Symporters | 6 | 2011 | 48 | 0.210 |
Why?
| | Transcription Factors | 7 | 2016 | 1739 | 0.210 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 79 | 0.200 |
Why?
| | Acute Lung Injury | 1 | 2026 | 302 | 0.190 |
Why?
| | Membrane Glycoproteins | 4 | 2020 | 496 | 0.190 |
Why?
| | RNA, Messenger | 14 | 2023 | 2829 | 0.190 |
Why?
| | Glycoproteins | 2 | 1995 | 355 | 0.190 |
Why?
| | Lung | 2 | 2026 | 4108 | 0.180 |
Why?
| | Cholangitis, Sclerosing | 1 | 2023 | 60 | 0.180 |
Why?
| | Animals, Newborn | 2 | 2024 | 901 | 0.180 |
Why?
| | Chenodeoxycholic Acid | 1 | 2021 | 12 | 0.180 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 14 | 0.180 |
Why?
| | Isoxazoles | 1 | 2021 | 53 | 0.170 |
Why?
| | Membrane Transport Proteins | 5 | 2007 | 154 | 0.170 |
Why?
| | Cell Line | 8 | 2020 | 2879 | 0.170 |
Why?
| | Macrophages | 3 | 2021 | 1510 | 0.170 |
Why?
| | Chromatin | 3 | 2015 | 561 | 0.160 |
Why?
| | Gene Expression | 2 | 2024 | 1487 | 0.160 |
Why?
| | DNA-Binding Proteins | 7 | 2013 | 1497 | 0.160 |
Why?
| | Interleukin-1beta | 2 | 2021 | 395 | 0.160 |
Why?
| | Biliary Atresia | 1 | 2020 | 157 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4556 | 0.140 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 634 | 0.140 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 39 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 1995 | 1313 | 0.130 |
Why?
| | Protein Transport | 4 | 2013 | 441 | 0.120 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2016 | 13 | 0.120 |
Why?
| | Methylation | 3 | 2012 | 242 | 0.120 |
Why?
| | 5-Methylcytosine | 1 | 2016 | 25 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2013 | 381 | 0.110 |
Why?
| | Amino Acid Substitution | 3 | 2013 | 304 | 0.110 |
Why?
| | I-kappa B Proteins | 1 | 2015 | 74 | 0.110 |
Why?
| | Apoptosis | 1 | 2024 | 2430 | 0.110 |
Why?
| | Radioisotope Teletherapy | 1 | 1995 | 2 | 0.110 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.110 |
Why?
| | Cobalt Radioisotopes | 1 | 1995 | 7 | 0.110 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2015 | 19 | 0.110 |
Why?
| | Lipid Peroxides | 1 | 1994 | 10 | 0.110 |
Why?
| | Glycoside Hydrolases | 1 | 1995 | 39 | 0.110 |
Why?
| | Histones | 3 | 2012 | 668 | 0.110 |
Why?
| | Haplorhini | 2 | 2012 | 52 | 0.110 |
Why?
| | Sialic Acids | 1 | 1994 | 8 | 0.110 |
Why?
| | Histone Deacetylases | 1 | 2016 | 210 | 0.110 |
Why?
| | Trans-Activators | 2 | 2008 | 405 | 0.100 |
Why?
| | Endothelin-1 | 1 | 2015 | 184 | 0.100 |
Why?
| | Glycolipids | 1 | 1994 | 52 | 0.100 |
Why?
| | Brachytherapy | 1 | 1995 | 134 | 0.100 |
Why?
| | Cadmium | 1 | 1994 | 68 | 0.100 |
Why?
| | Genetic Loci | 1 | 2015 | 261 | 0.100 |
Why?
| | Rats | 11 | 2009 | 5592 | 0.100 |
Why?
| | DNA Helicases | 1 | 2015 | 143 | 0.100 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 1 | 2013 | 15 | 0.100 |
Why?
| | Consensus Sequence | 1 | 2013 | 74 | 0.100 |
Why?
| | SUMO-1 Protein | 1 | 2013 | 22 | 0.100 |
Why?
| | Copper | 1 | 1994 | 113 | 0.100 |
Why?
| | Hep G2 Cells | 1 | 2013 | 74 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 2 | 2013 | 477 | 0.100 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2012 | 17 | 0.100 |
Why?
| | Glutathione | 1 | 1994 | 375 | 0.090 |
Why?
| | Cholesterol 7-alpha-Hydroxylase | 2 | 2003 | 2 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 224 | 0.090 |
Why?
| | Inflammation | 2 | 2023 | 2877 | 0.090 |
Why?
| | Cell Membrane | 2 | 2007 | 706 | 0.090 |
Why?
| | Carcinoma | 1 | 1994 | 227 | 0.090 |
Why?
| | Lysine | 2 | 2013 | 302 | 0.090 |
Why?
| | Zebrafish | 3 | 2002 | 528 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 336 | 0.090 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 130 | 0.090 |
Why?
| | Male | 13 | 2026 | 72035 | 0.090 |
Why?
| | Nuclear Receptor Coactivators | 1 | 2011 | 2 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 1994 | 442 | 0.080 |
Why?
| | Macrophage Activation | 2 | 2023 | 193 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 592 | 0.080 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 370 | 0.080 |
Why?
| | Zinc | 1 | 1994 | 294 | 0.080 |
Why?
| | Adenosine Triphosphatases | 2 | 2008 | 162 | 0.080 |
Why?
| | Steroid Hydroxylases | 3 | 2004 | 20 | 0.080 |
Why?
| | Humans | 24 | 2023 | 144261 | 0.080 |
Why?
| | Imino Acids | 1 | 2009 | 4 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2009 | 12 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1994 | 641 | 0.080 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2009 | 10 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2016 | 3539 | 0.080 |
Why?
| | Cell Cycle | 1 | 2012 | 596 | 0.070 |
Why?
| | Transcription, Genetic | 3 | 2013 | 1495 | 0.070 |
Why?
| | Lipoproteins | 2 | 2021 | 163 | 0.070 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 15 | 0.070 |
Why?
| | Arginine | 2 | 2013 | 262 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2008 | 56 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 1994 | 927 | 0.070 |
Why?
| | Protein Kinase C | 1 | 2008 | 252 | 0.070 |
Why?
| | Base Sequence | 5 | 2016 | 2187 | 0.060 |
Why?
| | Transfection | 5 | 2008 | 938 | 0.060 |
Why?
| | Molecular Chaperones | 1 | 2008 | 199 | 0.060 |
Why?
| | Bile Ducts | 2 | 2020 | 67 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1021 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 30 | 0.060 |
Why?
| | Cholesterol | 2 | 2004 | 399 | 0.060 |
Why?
| | Sterols | 2 | 2021 | 20 | 0.060 |
Why?
| | Organic Anion Transporters | 1 | 2005 | 13 | 0.060 |
Why?
| | Bile Canaliculi | 1 | 2004 | 4 | 0.060 |
Why?
| | Bile | 1 | 2004 | 26 | 0.050 |
Why?
| | Caco-2 Cells | 3 | 2013 | 79 | 0.050 |
Why?
| | Down-Regulation | 4 | 2011 | 627 | 0.050 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 95 | 0.050 |
Why?
| | Binding Sites | 5 | 2008 | 1327 | 0.050 |
Why?
| | Serine | 1 | 2005 | 145 | 0.050 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2004 | 25 | 0.050 |
Why?
| | Antioxidants | 2 | 2023 | 549 | 0.050 |
Why?
| | Molecular Sequence Data | 5 | 2013 | 2929 | 0.050 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2004 | 15 | 0.050 |
Why?
| | Homeostasis | 2 | 2024 | 640 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2024 | 55 | 0.050 |
Why?
| | Methyltransferases | 2 | 2016 | 74 | 0.050 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2024 | 72 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 207 | 0.050 |
Why?
| | Thioredoxin Reductase 1 | 1 | 2023 | 8 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2012 | 330 | 0.050 |
Why?
| | Taurocholic Acid | 3 | 2007 | 8 | 0.050 |
Why?
| | Hydroxysteroid Dehydrogenases | 1 | 2002 | 2 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2002 | 90 | 0.050 |
Why?
| | Hypercholesterolemia | 1 | 2003 | 92 | 0.050 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2002 | 54 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 81 | 0.040 |
Why?
| | Intestinal Diseases | 1 | 2021 | 43 | 0.040 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 169 | 0.040 |
Why?
| | Bilirubin | 1 | 2021 | 97 | 0.040 |
Why?
| | Infliximab | 1 | 2021 | 108 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2005 | 961 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 780 | 0.040 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 288 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 863 | 0.040 |
Why?
| | Female | 9 | 2026 | 77976 | 0.040 |
Why?
| | Plasmids | 2 | 2011 | 379 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 983 | 0.040 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.040 |
Why?
| | Retinoid X Receptors | 2 | 2013 | 38 | 0.030 |
Why?
| | Caspases, Initiator | 1 | 2018 | 17 | 0.030 |
Why?
| | Liver X Receptors | 1 | 2018 | 30 | 0.030 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 64 | 0.030 |
Why?
| | Lymphokines | 1 | 1998 | 130 | 0.030 |
Why?
| | Lipids | 1 | 2003 | 700 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2013 | 2154 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 148 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 213 | 0.030 |
Why?
| | Caspases | 1 | 2018 | 232 | 0.030 |
Why?
| | Lipid Peroxidation | 2 | 1994 | 160 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 181 | 0.030 |
Why?
| | Phosphofructokinase-1 | 1 | 2016 | 6 | 0.030 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2016 | 21 | 0.030 |
Why?
| | Blotting, Western | 2 | 2012 | 1187 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 40 | 0.030 |
Why?
| | Sirtuin 1 | 1 | 2016 | 34 | 0.030 |
Why?
| | Phosphorylation | 2 | 2012 | 1732 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2016 | 148 | 0.030 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2016 | 70 | 0.030 |
Why?
| | Sirtuins | 1 | 2016 | 50 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2015 | 113 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 1994 | 39 | 0.030 |
Why?
| | Catalase | 1 | 1994 | 130 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2015 | 96 | 0.030 |
Why?
| | N-Acetylneuraminic Acid | 1 | 1994 | 16 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 192 | 0.030 |
Why?
| | Ileum | 2 | 2006 | 111 | 0.030 |
Why?
| | Cholestanetriol 26-Monooxygenase | 2 | 2004 | 7 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 476 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 744 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 1994 | 301 | 0.020 |
Why?
| | Histone Demethylases | 1 | 2012 | 38 | 0.020 |
Why?
| | Point Mutation | 2 | 2005 | 243 | 0.020 |
Why?
| | Phylogeny | 3 | 2002 | 1015 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 148 | 0.020 |
Why?
| | Silver Nitrate | 1 | 2012 | 2 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2012 | 8 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2011 | 4146 | 0.020 |
Why?
| | Silver Staining | 1 | 2012 | 16 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2012 | 15 | 0.020 |
Why?
| | Middle Aged | 4 | 1995 | 35762 | 0.020 |
Why?
| | Oxazines | 1 | 2012 | 36 | 0.020 |
Why?
| | Furans | 1 | 2012 | 27 | 0.020 |
Why?
| | Benzopyrans | 1 | 2012 | 30 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 93 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2015 | 724 | 0.020 |
Why?
| | Glycosylation | 1 | 2012 | 172 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2012 | 150 | 0.020 |
Why?
| | Ketones | 1 | 2012 | 53 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2013 | 220 | 0.020 |
Why?
| | Obesity | 1 | 2004 | 3057 | 0.020 |
Why?
| | Ligation | 1 | 2011 | 92 | 0.020 |
Why?
| | Adult | 4 | 1995 | 40262 | 0.020 |
Why?
| | Vanadates | 1 | 1990 | 17 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 673 | 0.020 |
Why?
| | Glutathione Transferase | 1 | 2011 | 100 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2012 | 112 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 151 | 0.020 |
Why?
| | Fatty Acids | 2 | 2004 | 450 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 1994 | 1461 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2182 | 0.020 |
Why?
| | Cell Nucleus | 2 | 2004 | 618 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 329 | 0.020 |
Why?
| | In Situ Hybridization | 2 | 2002 | 319 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 684 | 0.020 |
Why?
| | Up-Regulation | 2 | 2004 | 851 | 0.020 |
Why?
| | Ochratoxins | 1 | 1989 | 2 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2002 | 396 | 0.020 |
Why?
| | Carbon Tetrachloride | 1 | 2009 | 13 | 0.020 |
Why?
| | Cloning, Molecular | 2 | 2002 | 539 | 0.020 |
Why?
| | Metabolic Clearance Rate | 1 | 2009 | 114 | 0.020 |
Why?
| | Radionuclide Imaging | 1 | 2009 | 112 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 1990 | 198 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 268 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2009 | 327 | 0.020 |
Why?
| | Dystonia Musculorum Deformans | 1 | 2008 | 3 | 0.020 |
Why?
| | Aniline Compounds | 1 | 2009 | 119 | 0.020 |
Why?
| | Glycine | 1 | 2009 | 187 | 0.020 |
Why?
| | Tourette Syndrome | 1 | 2008 | 27 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2009 | 451 | 0.020 |
Why?
| | Mutation | 2 | 2013 | 4085 | 0.020 |
Why?
| | Multigene Family | 1 | 2008 | 203 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 405 | 0.020 |
Why?
| | Estrone | 1 | 2007 | 40 | 0.020 |
Why?
| | Dimerization | 1 | 2007 | 193 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6424 | 0.010 |
Why?
| | Xenopus laevis | 1 | 2006 | 105 | 0.010 |
Why?
| | Case-Control Studies | 1 | 1994 | 3592 | 0.010 |
Why?
| | Electrophysiology | 1 | 2006 | 218 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 2005 | 26 | 0.010 |
Why?
| | Autoradiography | 1 | 2005 | 64 | 0.010 |
Why?
| | Dogs | 1 | 2007 | 437 | 0.010 |
Why?
| | Prognosis | 1 | 1994 | 4278 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2005 | 73 | 0.010 |
Why?
| | Oocytes | 1 | 2006 | 178 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 824 | 0.010 |
Why?
| | Sodium | 1 | 2006 | 197 | 0.010 |
Why?
| | Molecular Weight | 1 | 2005 | 327 | 0.010 |
Why?
| | 5' Untranslated Regions | 1 | 2005 | 59 | 0.010 |
Why?
| | Rats, Zucker | 1 | 2004 | 32 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2004 | 69 | 0.010 |
Why?
| | Immunosorbent Techniques | 1 | 2004 | 18 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2005 | 208 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 862 | 0.010 |
Why?
| | Alanine | 1 | 2005 | 171 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 369 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 674 | 0.010 |
Why?
| | Glucose | 1 | 1989 | 1046 | 0.010 |
Why?
| | Acetylation | 1 | 2004 | 252 | 0.010 |
Why?
| | Drug Synergism | 1 | 2004 | 357 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 462 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2004 | 114 | 0.010 |
Why?
| | Cytoplasm | 1 | 2004 | 269 | 0.010 |
Why?
| | Gallbladder | 1 | 2003 | 15 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 226 | 0.010 |
Why?
| | Receptors, LDL | 1 | 2003 | 53 | 0.010 |
Why?
| | Somites | 1 | 2002 | 5 | 0.010 |
Why?
| | Protein Folding | 1 | 2004 | 279 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 397 | 0.010 |
Why?
| | Steroid 12-alpha-Hydroxylase | 1 | 2002 | 1 | 0.010 |
Why?
| | 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 2002 | 1 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 276 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2002 | 245 | 0.010 |
Why?
| | TATA Box | 1 | 2001 | 22 | 0.010 |
Why?
| | Neural Crest | 1 | 2002 | 126 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 698 | 0.010 |
Why?
| | Receptors, Retinoic Acid | 1 | 2001 | 42 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 162 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2001 | 193 | 0.010 |
Why?
| | Drainage | 1 | 2002 | 185 | 0.010 |
Why?
| | Rabbits | 1 | 2002 | 648 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 275 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 976 | 0.010 |
Why?
| | Tretinoin | 1 | 2001 | 124 | 0.010 |
Why?
| | Mutagenesis | 1 | 2001 | 190 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 511 | 0.010 |
Why?
| | Genotype | 1 | 2004 | 1833 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 919 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 2096 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 803 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 80 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1998 | 204 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1367 | 0.010 |
Why?
| | Codon | 1 | 1998 | 94 | 0.010 |
Why?
| | Nervous System | 1 | 1998 | 70 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1460 | 0.010 |
Why?
| | Embryo, Nonmammalian | 1 | 1998 | 173 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2001 | 370 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2525 | 0.010 |
Why?
| | Mesoderm | 1 | 1998 | 150 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2003 | 676 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3157 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2840 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1782 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 557 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1998 | 458 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1998 | 1054 | 0.010 |
Why?
| | Liver Neoplasms | 1 | 2001 | 780 | 0.010 |
Why?
| | Aging | 1 | 2003 | 1964 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 321 | 0.010 |
Why?
| | Liver Glycogen | 1 | 1989 | 15 | 0.000 |
Why?
| | Pregnancy | 1 | 2003 | 7180 | 0.000 |
Why?
| | Aspergillus | 1 | 1989 | 18 | 0.000 |
Why?
| | Pyruvates | 1 | 1989 | 24 | 0.000 |
Why?
| | Infant | 1 | 2004 | 10022 | 0.000 |
Why?
| | Lactates | 1 | 1989 | 83 | 0.000 |
Why?
| | Liver Function Tests | 1 | 1989 | 106 | 0.000 |
Why?
| | Child, Preschool | 1 | 2004 | 11774 | 0.000 |
Why?
| | Child | 1 | 2004 | 22537 | 0.000 |
Why?
| | Diet | 1 | 1989 | 1271 | 0.000 |
Why?
| | Blood Glucose | 1 | 1989 | 2312 | 0.000 |
Why?
| | Insulin | 1 | 1989 | 2501 | 0.000 |
Why?
|
|
Balasubramaniyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|